Scott W. Woods
YOU?
Author Swipe
View article: Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative Open
View article: Shift in sex and age of individuals at a clinical high risk (CHR) for psychosis: relation to differences in recruitment methods and effect on sample characteristics
Shift in sex and age of individuals at a clinical high risk (CHR) for psychosis: relation to differences in recruitment methods and effect on sample characteristics Open
View article: Transdiagnostic connectome-based predictive modeling of many behavioral phenotypes reveals brain network mediators of clinical-cognitive relationships
Transdiagnostic connectome-based predictive modeling of many behavioral phenotypes reveals brain network mediators of clinical-cognitive relationships Open
Connectome-based predictive modeling (CPM) applied to functional MRI connectivity data can identify brain networks that vary with behavioral measures across subjects. The prediction strength also provides an index of how closely an externa…
View article: Excitation/inhibition imbalance and conversion to psychosis in the clinical high risk syndrome: Biophysical modeling finds reduced pyramidal cell excitability across EEG paradigms
Excitation/inhibition imbalance and conversion to psychosis in the clinical high risk syndrome: Biophysical modeling finds reduced pyramidal cell excitability across EEG paradigms Open
Background Reduced mismatch negativity (MMN) and P300 event-related potential (ERP) components are widely replicated in schizophrenia and are also observed in individuals at clinical high risk for psychosis (CHR-P) who subsequently convert…
View article: Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis: Methods and Preliminary Data
Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis: Methods and Preliminary Data Open
Background and Hypothesis Despite significant advances in our understanding of the clinical high risk (CHR) for psychosis state, the longer-term outcomes (5+ years) and the trajectory of diagnoses, symptoms, and psychosocial function have …
View article: Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms Open
The clinical high risk for psychosis (CHR-P) population is important for understanding disease progression and treatment; however, standard approaches to identifying CHR-P individuals are expensive and labor-intensive. Focusing on neurocog…
View article: Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for Psychosis
Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for Psychosis Open
Importance While remission from clinical high risk (CHR) for psychosis is a favorable outcome, it is not well characterized over time. Objective To examine remission incidence, prevalence, and stability, and their association with demograp…
View article: A Transdiagnostic fMRI Dataset With 300+ Deeply Phenotyped Subjects Across Resting and Task States.
A Transdiagnostic fMRI Dataset With 300+ Deeply Phenotyped Subjects Across Resting and Task States. Open
YaleNeuroConnect is a human functional MRI (fMRI) dataset collected at Yale University that includes functional MRI data (and the respective functional connectomes) obtained under resting-state and six task conditions. There are 302 diagno…
View article: Multisensory overweighting of perceptual priors relates to positive symptoms in individuals at clinical high risk of psychosis
Multisensory overweighting of perceptual priors relates to positive symptoms in individuals at clinical high risk of psychosis Open
View article: Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program Open
Although meta-analytic studies have shown that 25-33% of those at Clinical High Risk (CHR) for psychosis transition to a first episode of psychosis within three years, less is known about estimating the risk of transition at an individual …
View article: Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations Open
View article: Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates
Increased face perception in individuals at clinical high-risk for psychosis: mechanisms, sex differences, and clinical correlates Open
Altered visual perception has been observed across all phases of psychotic illness, suggesting that perceptual measures might be useful in identifying people at clinical high risk for psychosis (CHR). In a preliminary study, we found that …
View article: Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms
Identifying individuals at clinical high risk for psychosis using a battery of tasks sensitive to symptom mechanisms Open
View article: Altered brain activation during memory retrieval mediates the relationship between developmental trauma and psychotic symptom severity
Altered brain activation during memory retrieval mediates the relationship between developmental trauma and psychotic symptom severity Open
These findings suggest a role of episodic memory processing and inferior parietal lobe activation in the association between DT and psychosis. Focusing further on these measures could provide insight into the underlying mechanism of this a…
View article: Improving Quality Control of MRI Images Using Synthetic Motion Data
Improving Quality Control of MRI Images Using Synthetic Motion Data Open
Model weights used in our IBSI 2025 Paper : "Improving Quality Control of MRI Images Using Synthetic Motion Data" Pretained-SFCN : is our network pretrained on synthetic motion artifacts only SFCN-Scratch-X : are different models trained f…
View article: Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program
Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program Open
View article: Functional correlates of atypical visuoperceptual organization in a multisite clinical high-risk sample.
Functional correlates of atypical visuoperceptual organization in a multisite clinical high-risk sample. Open
Individuals at clinical high risk (CHR) for developing psychotic disorders are thought to exhibit atypical visuoperceptual organization. Furthermore, CHR status is associated with reduced cognitive, social, and role functioning. We hypothe…
View article: Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program
Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program Open
View article: Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program
Sample ascertainment and clinical outcome measures in the Accelerating Medicines Partnership® Schizophrenia Program Open
Clinical ascertainment and clinical outcome are key features of any large multisite study. In the ProNET and PRESCIENT research networks, the Accelerating Medicines Partnership® Schizophrenia (AMP®SCZ) Clinical Ascert…
View article: Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program
Enabling FAIR data stewardship in complex international multi-site studies: Data Operations for the Accelerating Medicines Partnership® Schizophrenia Program Open
Modern research management, particularly for publicly funded studies, assumes a data governance model in which grantees are considered stewards rather than owners of important data sets. Thus, there is an expectation that collected data ar…
View article: Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program Open
View article: The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program Open
View article: Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample Open
View article: Delineating empirically plausible causal pathways to suicidality among people at clinical high risk for psychosis.
Delineating empirically plausible causal pathways to suicidality among people at clinical high risk for psychosis. Open
Suicidality is common among people at clinical high risk (CHR) for psychosis. Delineating causal pathways to suicidality and identifying its determinants would inform tailored intervention efforts for these individuals. To this end, we ana…
View article: Predicting conversion to psychosis using machine learning: response to Cannon
Predicting conversion to psychosis using machine learning: response to Cannon Open
Background We previously reported that machine learning could be used to predict conversion to psychosis in individuals at clinical high risk (CHR) for psychosis with up to 90% accuracy using the North American Prodrome Longitudinal Study-…
View article: Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis
Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis Open
Background Antipsychotic (AP) medication in individuals at clinical high risk for psychosis (CHR-P) is not routinely recommended by clinical guidelines but is commonly prescribed. Since little is known about the predictors of AP inception …
View article: A generalized reward processing deficit pathway to negative symptoms across diagnostic boundaries
A generalized reward processing deficit pathway to negative symptoms across diagnostic boundaries Open
Background Negative symptoms are a key feature of several psychiatric disorders. Difficulty identifying common neurobiological mechanisms that cut across diagnostic boundaries might result from equifinality (i.e., multiple mechanistic path…
View article: Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program Open
Background This paper presents the recruitment sources of clinical high-risk (CHR) and community controls (CC) from the Accelerating Medicines Partnership Schizophrenia (AMP SCZ) program, which aims to study various clinical variables and …
View article: Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for Psychosis.
Mismatch Negativity as an Index of Auditory Short-Term Plasticity: Associations with Cortisol, Inflammation, and Gray Matter Volume in Youth at Clinical High Risk for Psychosis. Open
Mismatch negativity (MMN) event-related potential (ERP) component reduction, indexing N-methyl-D-aspartate receptor (NMDAR)-dependent auditory echoic memory and short-term plasticity, is a well-established biomarker of schizophrenia that i…
View article: Attention Deficit Hyperactivity Disorder among Youth at Clinical High Risk of Psychosis
Attention Deficit Hyperactivity Disorder among Youth at Clinical High Risk of Psychosis Open
Attention Deficit Hyperactivity Disorder (ADHD) affects a significant proportion of the population and is associated with numerous adverse outcomes including lower educational attainment, occupational challenges, increased substance use, a…